Consumer goods company Reckitt Benckiser on May 2 said like-for-like sales grew 1 percent in the first quarter of 2019 to 3.2 billion pounds, lower than the 1.8 percent predicted by analysts.
Like-for-like sales in the over-the-counter drugs business fell 9 percent to 470 million pounds, hit by a weak cold-and-flu season in the United States and several European countries. The 43 billion pound company said it was on track to meet its full-year net revenue target of 3 to 4 percent like-for-like sales growth.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: